MRI-guided Radiotherapy (MRgRT) for Treatment of Oligometastases: Review of Clinical Applications and Challenges
- 25 July 2022
- journal article
- review article
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 114 (5) , 950-967
Abstract
No abstract availableKeywords
Funding Information
- Varian Medical Systems
- Philips Oral Healthcare
- Pfizer
- Genentech
- ViewRay
This publication has 165 references indexed in Scilit:
- Multi-disciplinary management for patients with oligometastases to the brain: results of a 5 year cohort studyRadiation Oncology, 2013
- Stereotactic body radiotherapy for oligometastasesThe Lancet Oncology, 2013
- Aggressive Treatment of Primary Tumor in Patients With Non–Small-Cell Lung Cancer and Exclusively Brain MetastasesClinical Lung Cancer, 2013
- MRI simulation for radiotherapy treatment planningMedical Physics, 2012
- A new concept for non‐invasive renal tumour ablation using real‐time MRI‐guided radiation therapyBJU International, 2010
- Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung CancerJAMA, 2010
- Oligometastases and Oligo-recurrence: The New Era of Cancer TherapyJapanese Journal of Clinical Oncology, 2010
- Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Lung MetastasesJournal of Clinical Oncology, 2009
- Dose optimization for the MRI-accelerator: IMRT in the presence of a magnetic fieldPhysics in Medicine & Biology, 2007
- Adaptive radiation therapyPhysics in Medicine & Biology, 1997